Valneva SE (VALN) stock
VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 17, 2026Score 1/30
$5.34−0.23 (-4.04%)
Close on Nov 18, 2026Market cap $463.35MP/E –Yield –
Valneva market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Valneva's market cap was $561.35M on Nov 11, 2026, against $548.09M a year earlier. Over the last 3 years it ranged from $466.49M to $2.93B, with a median of $788.25M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $561.35M | -28.8% |
| 2025 | Oct 31, 2025 | $788.25M | +52.5% |
| 2024 | Apr 30, 2024 | $516.98M | -20.8% |
| 2023 | Apr 28, 2023 | $652.85M | -16.2% |
| 2022 | Oct 31, 2022 | $779.42M | -69.1% |
| 2021 | Dec 31, 2021 | $2.52B | – |
See a number that looks wrong?